Although mass spectrometry is making its mark on all facets of clinical laboratory medicine, arguably no field is witnessing its impact more than clinical microbiology. The application of MALDI-TOF mass spectrometry (MALDI-TOF MS) to microbial identification is revolutionizing clinical microbiology by providing rapid identification with minimal sample preparation at a potential savings in costs.
In the current issue of Clinical Chemistry, experts discussed this issue in this Q&A (free to access). We’d like to hear what you have to say about this topic.
What do you feel are the most significant contributions that implementation of MALDI-TOF MS can make in the clinical microbiology laboratory?
Share your opinion on this topic below. Be sure to check out all of our Q&As here.